Page 73 - Read Online
P. 73

Tang et al. Neuroimmunol Neuroinflammation 2021;8:64-9  I  http://dx.doi.org/10.20517/2347-8659.2020.28         Page 69

               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               This research was funded by the Carle Foundation Hospital and University of Illinois Cancer Scholars for
               Translational and Applied Research (C*STAR) Graduate Program.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               All experiments were approved in advance by the Institutional Animal Care and Use Committee of
               the University of Illinois (protocol 19002), whose animal programs are accredited by the AAALAC
               International and follow the NRC Guide for the Care and Use of Laboratory Animals, Eighth Edition.


               Consent for publication
               Not applicable.

               Copyright
               © The Author(s) 2021.

               REFERENCES
               1.   Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet 2012;205:613-21.
               2.   Hart MG, Garside R, Rogers G, Stein K, Grant R. Temozolomide for high grade glioma. Cochrane Database Syst Rev
                   2013;(4):CD007415.
               3.   Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, et al. CBTRUS statistical report: primary brain and central nervous system tumors
                   diagnosed in the United States in 2007-2011. Neuro Oncol 2014;16 Suppl 4:iv1-63.
               4.   Tang B, Guo ZS, Bartlett DL, Yan DZ, Schane CP, et al. Synergistic combination of oncolytic virotherapy and immunotherapy for glioma.
                   Clin Cancer Res 2020;26:2216-30.
               5.   Chen Z, Zhang P, Xu Y, Yan J, Liu Z, et al. Surgical stress and cancer progression: the twisted zo. Mol Cancer 2019;18:132.
               6.   Angka L, Martel AB, Kilgour M, Jeong A, Sadiq M, et al. Natural killer cell IFNγ secretion is profoundly suppressed following colorectal
                   cancer surgery. Ann Surg Oncol 2018;25:3747-54.
               7.   Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, et al. Suppression of cellular immunity by surgical stress. Surgery
                   2000;127:329-36.
               8.   Lissoni P, Brivio F, Fumagalli L, Messina G, Meregalli S, et al. Effects of the conventional antitumor therapies surgery, chemotherapy,
                   radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients. Anticancer Res 2009;29:1847-52.
               9.   Saito Y, Shimada M, Utsunomiya T, Morine Y, Imura S, et al. Regulatory T cells in the blood: a new marker of surgical stress. Surg Today
                   2013;43:608-12.
               10.   Kumagai Y, Ohzawa H, Miyato H, Horie H, Hosoya Y, et al. Surgical stress increases circulating low-density neutrophils which may
                   promote tumor recurrence. J Surg Res 2020;246:52-61.
               11.   Pellegatta S, Finocchiaro G. Dendritic cell vaccines for cancer stem cells. In: Yu JS, editor. Cancer Stem Cells. Totowa: Humana Press;
                   2009. pp. 233-47.
   68   69   70   71   72   73   74   75   76   77   78